CTRI/2009/091/000744Other3 期
The efficacy and safety of PDE-5 inhibitor Tadalafil in patients of Pulmonary Hypertension
Division of Cardiology,Department of Medicine,Mahatma Gandhi Memorial Medical College and M.Y.Hospital,Indore,India0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- Other
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •symptomatic patients >= 18 year of age with WHO Group I PAH
- •-Associated PAH:
- •congenital L -->R shunt
排除标准
- •Contraindication for Tadalafil or PDE-5 inhibitors,
- •Other WHO PAH Group (II, III, IV, V),
- •Patient not able to give informed consent,
- •Participation in another PAH trial or other trial (current or within one month of completion),
- •Patients with neuromuscular or orthopedic condition not permitting active participation,
- •with other medical illness limiting life expectancy < 6 months.
研究者
相似试验
进行中（未招募）
1 期
Efficacy of Tadalafil on the size and function of the right heart ventriclein adults with a congenital heart disease, whose right ventricle insteadof the left venrticle pumps blood in the body's circulation system.Adults with congenital heart disease (CHD) and a right ventricle (RV) insubaortic (systemic) position.EUCTR2016-004291-21-ATInsel Gruppe AG - Inselspital Universitätsklinik für Kardiologie98
Unknown
2 期
Efficacy and Safety of Tadalafil in Hemodialysis PatientsErectile DysfunctionNCT00334477University of Pernambuco60
已完成
不适用
Effects of tadalafil on postvoided dribblingKCT0002232Hallym University Medical Center- Chuncheon102
已完成
不适用
The efficacy and safety of Tadarafil for treatment of nocturia and sleep qualityJPRN-UMIN000018292Fujita Health University50
已完成
不适用
Study of the efficacy and safety of tadalafil and imidafenacin combination therapy for benign prostatic hyperplasia with overactive bladderBenign prostatic hyperplasia patients with overactive bladder despite tadalafil treatmentJPRN-UMIN000021959Kawahara Clinic30